These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Market watch: Upcoming catalysts in Q1 2015. Uribe A Nat Rev Drug Discov; 2015 Jan; 14(1):9. PubMed ID: 25503330 [No Abstract] [Full Text] [Related]
5. An audience with Luciano Rossetti. Interview by Bethan Hughes. Rossetti L Nat Rev Drug Discov; 2010 Oct; 9(10):758. PubMed ID: 20885401 [No Abstract] [Full Text] [Related]
6. Trends in the market for antihypertensive drugs. Ali MA; Rizvi S; Syed BA Nat Rev Drug Discov; 2017 May; 16(5):309-310. PubMed ID: 28280260 [No Abstract] [Full Text] [Related]
7. Upcoming market catalysts in Q4 2009. Jatkoe L Nat Rev Drug Discov; 2009 Oct; 8(10):763. PubMed ID: 19794437 [No Abstract] [Full Text] [Related]
8. Upcoming market catalysts in Q4 2019. Ranj T Nat Rev Drug Discov; 2019 Sep; 18(10):738. PubMed ID: 31570850 [No Abstract] [Full Text] [Related]
10. 25 top health care stocks. Will they lead the next market boom? Kane L Med Econ; 2001 Apr; 78(7):126-8, 133-6, 140-2. PubMed ID: 11368040 [No Abstract] [Full Text] [Related]
11. [PHARMACEUTICAL INDUSTRY AND PERSONALIZED MEDICINE: A PARADIGM SHIFT IN THE DEVELOPMENT OF NEW DRUGS]. Scheen AJ Rev Med Liege; 2015; 70(5-6):237-41. PubMed ID: 26285445 [TBL] [Abstract][Full Text] [Related]
12. Biopharmaceutical process development - shortcut to market: an interview with Rolf Werner from Boehringer Ingelheim. Jungbauer A; Göbel U Biotechnol J; 2012 Jan; 7(1):14-6. PubMed ID: 22228694 [No Abstract] [Full Text] [Related]
14. Vulnerability of health to market forces. Brezis M; Wiist WH Med Care; 2011 Mar; 49(3):232-9. PubMed ID: 21301368 [TBL] [Abstract][Full Text] [Related]
15. What makes a good forecaster? Earl J Nat Rev Drug Discov; 2003 Jan; 2(1):83. PubMed ID: 12521029 [No Abstract] [Full Text] [Related]
16. Drugs: budget busters or cost cutters in future health care? Egger E Health Care Strateg Manage; 1999 Mar; 17(3):1, 22-3. PubMed ID: 10351640 [No Abstract] [Full Text] [Related]
17. Ask the experts: future of the pharmaceutical industry. Interview by Future Medicinal Chemistry. Cottens S; Eaton M; Fuhr J; Geary S; Johnson DS; Li G; Raveglia L; Robertson GM; Westwell A Future Med Chem; 2011 Nov; 3(15):1863-72. PubMed ID: 22023030 [TBL] [Abstract][Full Text] [Related]
18. DAKOTACARE update: how PhRMA is changing their approach to key generic launches, observations in the marketplace. Weiss D S D Med; 2013 Jun; 66(6):245-6. PubMed ID: 23923686 [No Abstract] [Full Text] [Related]
19. Planning for US Precision Medicine Initiative underway. Jaffe S Lancet; 2015 Jun; 385(9986):2448-9. PubMed ID: 26122056 [No Abstract] [Full Text] [Related]
20. In vogue with venture. Patou G Nat Biotechnol; 2011 Nov; 29(11):967-9. PubMed ID: 22175076 [No Abstract] [Full Text] [Related] [Next] [New Search]